National Comprehensive Cancer Network



About NCCN

Ovarian Cancer Panel - Disclosures as of 2/28/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ronald D. Alvarez, MD

None

Genentech, Inc.

None

None

8/27/2014

Deborah K. Armstrong, MD

None

Genentech, Inc.;
Morphotek Inc.

None

None

10/11/2013

Barry Boston, MD

None

None

None

None

10/19/2011

Robert Burger, MD, FACOG, FACS

Genentech, Inc.

Champions Biotech;
Clovis Oncology;
Endocyte;
Nektar;
sanofi-aventis U.S.

None

GlaxoSmithKline

3/22/2013

Mariana Castells, MD, PhD

None

None

None

None

1/30/2012

Lee-may Chen, MD

None

None

None

None

8/28/2014

Larry Copeland, MD

None

Boehringer Ingelheim GmbH;
Eisai Inc.;
Genentech, Inc.

None

None

7/20/2014

Marta Ann Crispens, MD

None

None

None

None

5/5/2014

Mary Dwyer, MS

None

None

None

None

3/7/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

David M. Gershenson, MD

None

None

Johnson & Johnson;
Elsevier;
Informa;
Up to Date;
Pfizer Inc.

National Cancer Institute

7/30/2014

Heidi J. Gray, MD

None

Prima Biomed

None

None

8/29/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Ardeshir Hakam, MD

None

None

None

None

5/1/2014

Laura J. Havrilesky, MD

None

BD-TriPath Oncology

None

None

10/28/2013

Miranda Hughes, PhD

None

None

None

None

4/21/2014

Carolyn Johnston, MD

None

None

None

american cancer society-great lakes division;
michigan cancer consortium

9/24/2014

Shashikant Lele, MD

None

None

None

None

9/5/2013

Lainie Martin, MD

None

None

None

None

2/4/2014

Ursula A. Matulonis, MD

AstraZeneca Pharmaceuticals LP;
Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.

Eisai Inc.;
Merck & Co., Inc.

None

None

10/28/2013

Joan S. McClure, MS

None

None

None

None

6/20/2014

Robert J. Morgan, MD, FACP

NIH-CTEP

None

None

None

8/28/2014

David M. O'Malley, MD

None

Genentech, Inc.;
Johnson & Johnson

None

None

9/1/2014

Richard T. Penson, MD, MRCP

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
Endocyte Inc.

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Biomarin Pharmaceuticals, Inc.;
Clovis Oncology;
Lifecore Biomedical

None

None

9/2/2014

Steven W. Remmenga, MD

None

None

None

None

5/2/2014

Paul Sabbatini, MD

Prim Biomed

None

None

None

3/22/2014

Julian C. Schink, MD

None

Genentech, Inc.

None

None

3/8/2013

Nelson Teng, MD, PhD

None

None

None

None

5/5/2014

Theresa L. Werner, MD

None

None

None

None

5/2/2014